Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 19th September, 2024 Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 18th September, 2024. Concord Biotech shares hit all time high; Antique Broking reiterates 'Buy'
Antique Broking is bullish on Concord's business model, new launches and niche products Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith. kindly take the same into your records. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated August 07, 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for the First Quarter ended on June 30, 2024, we wish to inform that the said Earning Call was held today at 03:30 PM (IST). Kindly take the above on records. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosed Kindly take the above on records Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI(LODR) Regulation, 2015, Please find enclosed herewith Extract of the unaudited standalone and consolidated Financial Results for the first quarter ended June 30, 2024,as published in the below Newspaper on August 10, 2024 Kindly take the above on records Concord Biotech Ltd - 543960 - Financial Results For 30/06/2024
Unaudited Standalone and Consolidated Financial Statement for the first quarter ended june 30, 2024 Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcomes Of Board Meeting For The Unaudited Financials Results For The First Quarter Ended On June 30, 2024
With reference to the intimation of Board meeting submitted on July 31, 2024, we would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Friday, August 09, 2024, has inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the First quarter ended on June 30, 2024. The said results were also reviewed by the Audit Committee of the Company in its meeting held on August 09, 2024.